|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/26 | (2006.01) |
| A61P 3/10 | (2006.01) | ||
| A61P 7/12 | (2006.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 9/04 | (2006.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 13/12 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61K 47/02 | (2006.01) | ||
| A61K 47/10 | (2017.01) |
| (11) | Number of the document | 3423082 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17710160.7 |
| Date of filing the European patent application | 2017-03-03 | |
| (97) | Date of publication of the European application | 2019-01-09 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/054990 |
| Date | 2017-03-03 |
| (87) | Number | WO 2017/149112 |
| Date | 2017-09-08 |
| (30) | Number | Date | Country code |
| 16158739 | 2016-03-04 | EP | |
| 16173917 | 2016-06-10 | EP | |
| 16001329 | 2016-06-13 | EP | |
| 201715401651 | 2017-01-09 | US |
| (72) |
RASMUSSEN, Søren , DK
KVIST, Kajsa , DK
|
| (73) |
Novo Nordisk A/S ,
Novo Allé, 2880 Bagsværd,
DK
|
| (54) | LIRAGLUTIDE IN CARDIOVASCULAR CONDITIONS |
| LIRAGLUTIDE IN CARDIOVASCULAR CONDITIONS |